Komori
Toho Holdings (8129) · InitiativeAdvanced

Making information provision services a core business activity and strengthening the profit strategy

First written in FY2024-Q1. 1 of 3 entries say "Restated". Latest entry: FY2024.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2024-Q1 – FY2024-Q32023: 120232024: 22024
Same theme, other companies
Making information services a core business and strengthening revenue managementA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024AdvancedAnnual report

    「This change was made to present the results of the Group's sales activities more appropriately following the positioning of information services as one of its core sales activities.」

    Revenue from information service fees and other items was reclassified from non-operating income to net sales, increasing reported net sales and operating income by ¥3,552 million year on year. The position of information services as a sales activity was clarified.
  2. FY2024-Q3RestatedAnnual report

    「In undertaking the transformation of the wholesale business, one of the specific initiatives identified in our plan, Toho Pharmaceutical Co., Ltd., a consolidated subsidiary, reorganized its structure and strengthened the formulation, execution, and management of profit strategies, including revenue from information service fees.」

    We reaffirmed our policy of positioning information services as one of our core sales activities and strengthening the formulation, execution, and management of the profit strategy at Toho Pharmaceutical.
  3. FY2024-Q1First statedAnnual report

    「Toho Pharmaceutical Co., Ltd., a consolidated subsidiary, has reorganized its structure and is strengthening the formulation, execution, and management of profit strategies, including revenue from information services.」

    Information services, including revenue from information service fees, were positioned as a core sales activity, and Toho Pharmaceutical strengthened the formulation, execution, and management of its profit strategy. In addition, revenue from information service fees and other items was reclassified from non-operating income to net sales.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Toho Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Making information provision services a core business activity and strengthening the profit strategy | TOHO HOLDINGS CO.,LTD. (8129) | Komori